Contribution of the Platelia Candida-specific antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults

Journal of Clinical Microbiology

Volumn 41, Issue 10, 2003, Pages 4551-4558

  Sendid, Boualem ^a,b   Caillot, Denis ^c   Baccouch Humbert, Bénédicte ^b   Klingspor, Lena ^d   Grandjean, Monique ^c   Bonnin, Alain ^c   Poulain, Daniel ^a,b  

^a INSERM   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c HÔPITAL DU BOCAGE   (France)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBODY; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; BETA LACTAM ANTIBIOTIC; BIOCHEMICAL MARKER; CANDIDA ANTIGEN; FLUCONAZOLE; ITRACONAZOLE; PYRROLE DERIVATIVE; TEICOPLANIN; VANCOMYCIN; VORICONAZOLE;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; APLASIA; ARTICLE; ASPERGILLOSIS; BLOOD CULTURE; CANDIDA TROPICALIS; CANDIDIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; FEBRILE NEUTROPENIA; FEMALE; FUNGUS CULTURE; FUNGUS ISOLATION; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; CANDIDA; CANDIDA TROPICALIS; CANDIDIASIS; FEMALE; FUNGEMIA; HUMANS; MALE; MANNANS; MIDDLE AGED; NEUTROPENIA; REAGENT KITS, DIAGNOSTIC;

CANDIDA; CANDIDA TROPICALIS; FUNGI;

EID: 0141923863     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.10.4551-4558.2003     Document Type: Article

References (49)

1. Anaissie, E. J., J. H. Rex, O. Uzun, and S. Vartivarian. 1998. Predictors of adverse outcome in cancer patients with candidemia. Am. J. Med. 104:238-245.
2. Ascioglu, S., J. H. Rex, B. de Pauw, J. E. Bennett, J. Bille, F. Crokaert, D. W. Denning, J. P. Donnelly, J. E. Edwards, Z. Erjavec, D. Fiere, O. Lortholary, J. Maertens, J. F. Meis, T. F. Patterson, J. Ritter, D. Selleslag, P. M. Shah, D. A. Stevens, and T. J. Walsh. 2002. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis. 34:7-14.
3. Bodey, G. 1993. Candidiasis. Pathogenesis, diagnosis, and treatment, 2nd ed. Raven Press, New York, N.Y. 420.
4. Bodey, G., B. Bueltmann, W. Duguid, D. Gibbs, H. Hanak, M. Hotchi, G. Mall, P. Martino, F. Meunier, S. Milliken, et al. 1992. Fungal infections in cancer patients: an international autopsy survey. Eur. J. Clin. Microbiol. Infect. Dis. 11:99-109.
5. Bougnoux, M. E., S. Morand, and C. d'Enfert. 2002. Usefulness of multilocus sequence typing for characterization of clinical isolates of Candida albicans. J. Clin. Microbiol. 40:1290-1297.
6. Casadevall, A., A. Cassone, F. Bistoni, J. E. Cutler, W. Magliani, J. W. Murphy, L. Polonelli, and L. Romani. 1998. Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute? Med. Mycol. 36(Suppl. 1):95-105.
7. Denning, D. W., E. G. Evans, C. C. Kibbler, M. D. Richardson, M. M. Roberts, T. R. Rogers, D. W. Warnock, R. E. Warren, et al. 1997. Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. Eur. J. Clin. Microbiol. Infect. Dis. 16:424-436.
8. Edwards, J. E., G. P. Bodey, R. A. Bowden, T. Buchner, B. E. de Pauw, S. G. Filler, M. A. Ghannoum, M. Glauser, R. Herbrecht, C. A. Kauffman, S. Kohno, P. Martino, F. Meunier, T. Mori, M. A. Pfaller, J. H. Rex, T. R. Rogers, R. H. Rubin, J. Solomkin, C. Viscoli, T. J. Walsh, and M. White. 1997. International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin. Infect. Dis. 25:43-59.
9. Erjavec, Z., and P. E. Verweij. 2002. Recent progress in the diagnosis of fungal infections in the immunocompromised host. Drug Resist. Update 5:3-10.
10. Faille, C., D. W. Mackenzie, J. C. Michalski, and D. Poulain. 1992. Evaluation of an enzyme immunoassay using neoglycolipids constructed from Candida albicans oligomannosides to define the specificity of anti- mannan antibodies. Eur. J. Clin. Microbiol. Infect. Dis. 11:438-446.
11. Freydiere, A. M., R. Guinet, and P. Boiron. 2001. Yeast identification in the clinical microbiology laboratory: phenotypical methods. Med. Mycol. 39:9-33.
12. Gaytan-Martinez, J., E. Mateos-Garcia, E. Sanchez-Cortes, J. Gonzalez-Llaven, L. J. Casanova-Cardiel, and J. L. Fuentes-Allen. 2000. Microbiological findings in febrile neutropenia. Arch. Med. Res. 31:388-392.
13. Groll, A. H., P. M. Shah, C. Mentzel, M. Schneider, G. Just-Nuebling, and K. Huebner. 1996. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J. Infect. 33:23-32.
14. Han, Y., M. H. Riesselman, and J. E. Cutler. 2000. Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody. Infect. Immun. 68:1649-1654.
15. Hebart, H., J. Loeffler, L. Kanz, and H. Einsele. 2000. Molecular methods in the diagnosis of infections in the immunocompromised host. Curr. Opin. Infect. Dis. 13:355-359.
16. Hoffman, H. L., and R. C. Rathbun. 2002. Review of the safety and efficacy of voriconazole. Expert Opin. Investig. Drugs 11:409-429.
17. Hyams, K. C. 1998. Developing case definitions for symptom-based conditions: the problem of specificity. Epidemiol. Rev. 20:148-156.
18. Jacquinot, P. M., Y. Plancke, B. Sendid, G. Strecker, and D. Poulain. 1998. Nature of Candida albicans-derived carbohydrate antigen recognized by a monoclonal antibody in patient sera and distribution over Candida species. FEMS Microbiol. Lett. 169:131-138.
19. Jarvis, W. R. 1995. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin. Infect. Dis. 20:1526-1530.
20. Kontoyiannis, D. P., I. Vaziri, H. A. Hanna, M. Boktour, J. Thornby, R. Hachem, G. P. Bodey, and I. I. Raad. 2001. Risk factors for Candida tropicalis fungemia in patients with cancer. Clin. Infect. Dis. 33:1676-1681.
21. Loeffler, J., K. Schmidt, H. Hebart, U. Schumacher, and H. Einsele. 2002. Automated extraction of genomic DNA from medically important yeast species and filamentous fungi by using the MagNA Pure LC system. J. Clin. Microbiol. 40:2240-2243.
22. Maertens, J., J. Verhaegen, K. Lagrou, J. Van Eldere, and M. Boogaerts. 2001. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 97:1604-1610.
23. Maertens, J., M. Vrebos, and M. Boogaerts. 2001. Assessing risk factors for systemic fungal infections. Eur. J. Cancer Care 10:56-62.
24. Martinez, J. P., M. L. Gil, J. L. Lopez-Ribot, and W. L. Chaffin. 1998. Serologic response to cell wall mannoproteins and proteins of Candida albicans. Clin. Microbiol. Rev. 11:121-141.
25. Martino, P., C. Girmenia, A. Micozzi, R. Raccah, G. Gentile, M. Venditti, and F. Mandelli. 1993. Fungemia in patients with leukemia. Am. J. Med. Sci. 306:225-232.
26. Martino, R., and M. Subira. 2002. Invasive fungal infections in hematology: new trends. Ann. Hematol. 81:233-243.
27. Meyers, J. D. 1990. Fungal infections in bone marrow transplant patients. Semin. Oncol. 17:10-13.
28. Miyazaki, T., S. Kohno, K. Mitsutake, S. Maesaki, K. Tanaka, N. Ishikawa, and K. Hara. 1995. Plasma (1->3)-β-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J. Clin. Microbiol. 33:3115-3118.
29. Pagano, L., A. Antinori, A. Ammassari, L. Mele, A. Nosari, L. Melillo, B. Martino, M. Sanguinetti, F. Equitani, F. Nobile, M. Carotenuto, E. Morra, G. Morace, and G. Leone. 1999. Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes. Eur. J. Haematol. 63:77-85.
30. Pfaller, M. A. 1996. Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin. Infect. Dis. 22:S89-S94.
31. Podzorski, R. P., G. R. Gray, and R. D. Nelson. 1990. Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in vitro. J. Immunol. 144:707-716.
32. Ponton, J., and G. Quindos. 2002. Non-culture-based diagnostics, p. 393-425. In R. A. Calderone (ed.), Candida and candidiasis. American Society for Microbiology, Washington, D.C.
33. Rentz, A. M., M. T. Halpern, and R. Bowden. 1998. The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin. Infect. Dis. 27:781-788,
34. Rex, J. H., T. J. Walsh, J. D. Sobel, S. G. Filler, P. G. Pappas, W. E. Dismukes, J. E. Edwards, et al. 2000. Practice guidelines for the treatment of candidiasis. Clin. Infect. Dis. 30:662-678.
35. Rossetti, F., D. L. Brawner, R. Bowden, W. G. Meyer, H. G. Schoch, L. Fisher, D. Myerson, R. C. Hackman, H. M. Shulman, G. E. Sale, et al. 1995. Fungal liver infection in marrow transplant recipients: prevalence at autopsy, predisposing factors, and clinical features. Clin. Infect. Dis. 20:801-811.
36. Sendid, B., J. L. Poirot, M. Tabouret, A. Bonnin, D. Caillot, D. Camus, and D. Poulain. 2002. Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J. Med. Microbiol. 51:433-442.
37. Sendid, B., M. Tabouret, J. L. Poirot, D. Mathieu, J. Fruit, and D. Poulain. 1999. New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis. J. Clin. Microbiol. 37:1510-1517.
38. Stevens, D. A. 2002. Diagnosis of fungal infections: current status. J. Antimicrob. Chemother. 49(Suppl. 1):11-19.
39. Stone, E. A., H. B. Fung, and H. L. Kirschenbaum. 2002. Caspofungin: an echinocandin antifungal agent. Clin. Ther. 24:351-377.
40. Suzuki, S. 1997. Immunochemical study on mannans of genus Candida. I. Structural investigation of antigenic factors 1, 4, 5, 6, 8, 9, 11, 13, 13b and 34. Curr. Top. Med. Mycol. 8:57-70.
41. Switchenko, A. C., C. G. Miyada, T. C. Goodman, T. J. Walsh, B. Wong, M. J. Becker, and E. F. Ullman. 1994. An automated enzymatic method for measurement of D-arabinitol, a metabolite of pathogenic Candida species. J. Clin. Microbiol. 32:92-97.
42. Trinel, P. A., C. Faille, P. M. Jacquinot, J. C. Cailliez, and D. Poulain. 1992. Mapping of Candida albicans oligomannosidic epitopes by using monoclonal antibodies. Infect. Immun. 60:3845-3851.
43. Verweij, P. E., and J. F. Meis. 2000. Microbiological diagnosis of invasive fungal infections in transplant recipients. Transplant. Infect. Dis. 2:80-87.
44. Viscoli, C., C. Girmenia, A. Marinus, L. Collette, P. Martino, B. Vandercam, C. Doyen, B. Lebeau, D. Spence, V. Kremery, B. De Pauw, and F. Meunier. 1999. Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin. Infect. Dis. 28:1071-1079.
45. Warnock, D. W. 1998. Fungal infections in neurropenia: current problems and chemotherapeutic control. J. Antimicrob. Chemother. 41(Suppl. D):95-105.
46. Wenzel, R. P. 1995. Nosocomial candidemia: risk factors and attributable mortality. Clin. Infect. Dis. 20:1531-1534.
47. Wingard, J. R., and H. L. Leather. 2001. Empiric antifungal therapy for the neutropenic patient. Oncology (Huntington) 15:351-363.
48. Yeo, S. F., and B. Wong. 2002. Current status of nonculture methods for diagnosis of invasive fungal infections. Clin. Microbiol. Rev. 15:465-484.
49. Yera, H., B. Sendid, N. Francois, D. Camus, and D. Poulain. 2001. Contribution of serological tests and blood culture to the early diagnosis of systemic candidiasis. Eur. J. Clin. Microbiol. Infect. Dis. 20:864-870.